Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

AN Hata, MJ Niederst, HL Archibald…�- Nature medicine, 2016 - nature.com
Although mechanisms of acquired resistance of epidermal growth factor receptor (EGFR)-
mutant non-small-cell lung cancers to EGFR inhibitors have been identified, little is known�…
Save Cite Cited by 938 Related articles

[CITATION][C] Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

AN Hata, MJ Niederst, HL Archibald…�- Nature Medicine, 2016 - cir.nii.ac.jp
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth
factor receptor inhibition | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ]�…
Cite

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

AN Hata, MJ Niederst, HL Archibald…�- Nature Medicine, 2016 - go.gale.com
Although mechanisms of acquired resistance of epidermal growth factor receptor (EGFR)-
mutant non-small-cell lung cancers to EGFR inhibitors have been identified, little is known�…
Cite
[HTML] nih.gov

[HTML][HTML] Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

AN Hata, MJ Niederst, HL Archibald…�- Nature�…, 2016 - ncbi.nlm.nih.gov
Although mechanisms of acquired resistance of EGFR mutant non-small cell lung cancers to
EGFR inhibitors have been identified, little is known about how resistant clones evolve�…
Cite

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

AN Hata, MJ Niederst, HL Archibald…�- Nature�…, 2016 - dash.harvard.edu
Although mechanisms of acquired resistance of EGFR mutant non-small cell lung cancers to
EGFR inhibitors have been identified, little is known about how resistant clones evolve�…
Cite

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition.

AN Hata, MJ Niederst, HL Archibald…�- Nature�…, 2016 - europepmc.org
Although mechanisms of acquired resistance of EGFR mutant non-small cell lung cancers to
EGFR inhibitors have been identified, little is known about how resistant clones evolve�…
Cite

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

AN Hata, MJ Niederst, HL Archibald…�- Nature�…, 2016 - pubmed.ncbi.nlm.nih.gov
Although mechanisms of acquired resistance of epidermal growth factor receptor (EGFR)-
mutant non-small-cell lung cancers to EGFR inhibitors have been identified, little is known�…
Cite

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

AN Hata, MJ Niederst, HL Archibald…�- NATURE�…, 2016 - iris.unito.it
Although mechanisms of acquired resistance of epidermal growth factor receptor (EGFR)-
mutant non-small-cell lung cancers to EGFR inhibitors have been identified, little is known�…
Cite

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition.

AN Hata, MJ Niederst, HL Archibald…�- Nature�…, 2016 - europepmc.org
Although mechanisms of acquired resistance of EGFR mutant non-small cell lung cancers to
EGFR inhibitors have been identified, little is known about how resistant clones evolve�…
Cite

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

AN Hata, MJ Niederst, HL Archibald…�- Nature�…, 2016 - pubmed.ncbi.nlm.nih.gov
Although mechanisms of acquired resistance of epidermal growth factor receptor (EGFR)-
mutant non-small-cell lung cancers to EGFR inhibitors have been identified, little is known�…
Cite